Webinar
ENETS-NANETS-Webinar: New insights, directions & signals
This joint ENETS-NANETS webinar will illuminate current trials including Paltusotine, two DLL3 trials, anti-CD2000R1, Alphamedix, ACTION-1, and TECANT ERA. Expert panellists from both societies will focus discussions and comment on how these trials could provide new insights, directions, and signals in clinical NET practice.
Educational Level:
Advanced
Keywords:
Downloads:
Agenda:
Opening - Chandrikha CHANDRASEKHARAN
Current trials (20 mins)
-
- Paltusotine, 2 DLL3 trials and anti CD2000R1 – Jaume CAPDEVILA
- Alphamedix, ACTION-1, and TECANT ERA – Daniel HALPERIN
Discussion (15 mins)
Panel: Chandrikha CHANDRASEKHARAN, Luka LEŽAIČ, Thomas HOPE, Amr MOHAMED + presenters
Closing - Chandrikha CHANDRASEKHARAN
Moderators:
Speakers:
